Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (118)

2024

  1. Cassandra and A Room of One's Own: A common cry of frustration

    Nursing Inquiry, Vol. 31, Núm. 4

  2. Circulating biomarkers of myocardial remodelling: current developments and clinical applications

    Heart, Vol. 110, Núm. 19, pp. 1157-1163

  3. Clinical utility of personalized reference intervals for CEA in the early detection of oncologic disease

    Clinical Chemistry and Laboratory Medicine

  4. Comparison of Myocardial Blood Flow Quantification Models for Double ECG Gating Arterial Spin Labeling MRI: Reproducibility Assessment

    Journal of Magnetic Resonance Imaging

  5. Diagnostic and Prognostic Potential of Multiparametric Renal MRI in Kidney Transplant Patients

    Journal of Magnetic Resonance Imaging

  6. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  7. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  8. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  9. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  10. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

    Hypertension, Vol. 81, Núm. 2, pp. 218-228

  11. Nomenclature in palliative care and renal support: Not just at the end-of-life

    Nefrologia, Vol. 44, Núm. 4, pp. 475-485

  12. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

    Nature Medicine, Vol. 30, Núm. 7, pp. 2020-2029

  13. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102